M
Moderna, Inc. (MRNA)
49.56
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
49.56
0.00 (0.00%)
This stock has a consensus price target of $46.76 based on the ratings of 24 analysts. The high is $110.00 and the low is $18.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 18 | $ 46.76 | $ 110 |
| O’zgarish | -63.68% | -5.65% | 121.95% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-02-23 | 39.23% | Piper Sandler | $63 → $69 | Maintains | Overweight |
| 2026-02-17 | -17.27% | Goldman Sachs | $36 → $41 | Maintains | Neutral |
| 2026-02-17 | -39.47% | RBC Capital | $25 → $30 | Maintains | Sector Perform |
| 2026-02-17 | -29.38% | Evercore ISI Group | $28 → $35 | Maintains | In-Line |
| 2026-01-07 | -31.4% | UBS | $40 → $34 | Assumes | Buy → Neutral |